Does obesity prevent the needle from reaching muscle in intramuscular injections?

Basit Öğe Kaydı
dc.contributor.authorZaybak, Ayten
dc.contributor.authorGunes, Ulku Yapucu
dc.contributor.authorTamsel, Sadik
dc.contributor.authorKhorshid, Leyla
dc.contributor.authorEser, Ismet
dc.date.accessioned2019-10-27T19:34:12Z
dc.date.available2019-10-27T19:34:12Z
dc.date.issued2007
dc.departmentEge Üniversitesien_US
dc.description.abstractAim. This paper is a report of a study to measure subcutaneous tissue thickness at the dorsogluteal and ventrogluteal sites and to determine optimal needle length for dorsogluteal and ventrogluteal intramuscular injections in adults with a body mass index of more than 24.9 kg/m(2). Background. Problems can arise if drugs designed to be absorbed from muscle are only delivered into subcutaneous tissue. Increasing obesity in all developed and many developing countries makes this an increasing concern. Methods. Ultrasound measurements were made of the subcutaneous tissue of overweight, obese and extremely obese people at the dorsogluteal and ventrogluteal sites with the probe held at a 90 degrees angle to the plane of the injection site. Subcutaneous tissue thickness was measured in 119 adults whose body mass index was >= 25 kg/m(2). The data were collected in 2005-2006. Results. Mean subcutaneous tissue thickness at the dorsogluteal site was 34.5 mm for overweight adults, 40.2 mm for obese adults and 51.4 mm for extremely obese adults, and at the ventrogluteal site was 38.2 mm for overweight adults, 43.1 mm for obese adults and 53.8 mm for extremely obese adults. Conclusions. Intramuscular injections administered at the dorsogluteal site in 98% of women and 37% of men, and at the ventrogluteal site in 97% of women and 57% of men, would not reach the muscles of the buttock. A needle longer that 1.5 inches should be used in women whose body mass index is more than 24.9 kg/m(2), the dorsogluteal site may be used in all overweight and obese men, and the ventrogluteal site may be used in overweight men only.en_US
dc.identifier.doi10.1111/j.1365-2648.2007.04265.xen_US
dc.identifier.endpage556en_US
dc.identifier.issn0309-2402
dc.identifier.issue6en_US
dc.identifier.pmid17484745en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage552en_US
dc.identifier.urihttps://doi.org/10.1111/j.1365-2648.2007.04265.x
dc.identifier.urihttps://hdl.handle.net/11454/39595
dc.identifier.volume58en_US
dc.identifier.wosWOS:000247132300004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBlackwell Publishingen_US
dc.relation.ispartofJournal of Advanced Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectempirical research reporten_US
dc.subjectintramuscular injectionen_US
dc.subjectneedle lengthen_US
dc.subjectnursingen_US
dc.subjectobesityen_US
dc.subjectsubcutaneous tissueen_US
dc.subjectultrasounden_US
dc.titleDoes obesity prevent the needle from reaching muscle in intramuscular injections?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu